• Cat-intel
  • MedIntelliX
  • Resources
  • About Us
  • Request Free Sample ×

    Kindly complete the form below to receive a free sample of this Report

    Leading companies partner with us for data-driven Insights

    clients tt-cursor
    Hero Background

    US Osteoarthritis Market

    ID: MRFR/Pharma/16454-HCR
    100 Pages
    MRFR Team
    October 2025

    United States Osteoarthritis Market Research Report to 2032

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    US Osteoarthritis Market Infographic
    Purchase Options

    US Osteoarthritis Market Summary

    The US Osteoarthritis market is projected to experience substantial growth, reaching 541.32 USD Billion by 2035.

    Key Market Trends & Highlights

    US Osteoarthritis Key Trends and Highlights

    • The market valuation for US Osteoarthritis is estimated at 235.94 USD Billion in 2024.
    • From 2025 to 2035, the market is expected to grow at a compound annual growth rate of 7.84%.
    • By 2035, the market is anticipated to expand to 541.32 USD Billion, indicating a robust upward trajectory.
    • Growing adoption of innovative treatment options due to increasing prevalence of osteoarthritis is a major market driver.

    Market Size & Forecast

    2024 Market Size 235.94 (USD Billion)
    2035 Market Size 541.32 (USD Billion)
    CAGR (2025 - 2035) 7.84%

    Major Players

    Apple Inc (US), Microsoft Corp (US), Amazon.com Inc (US), Alphabet Inc (US), Berkshire Hathaway Inc (US), Meta Platforms Inc (US), Tesla Inc (US), Johnson & Johnson (US), Visa Inc (US), Procter & Gamble Co (US)

    Key Companies in the US Osteoarthritis Market market include

    FAQs

    What is the projected market size of the US Osteoarthritis Market in 2024?

    The US Osteoarthritis Market is expected to be valued at 1.1 billion USD in 2024.

    What is the anticipated market value for the US Osteoarthritis Market by 2035?

    By 2035, the US Osteoarthritis Market is projected to reach a value of 2.9 billion USD.

    What is the expected CAGR for the US Osteoarthritis Market from 2025 to 2035?

    The expected CAGR for the US Osteoarthritis Market during this period is 9.213%.

    Which type of osteoarthritis is expected to dominate the market?

    Hip Osteoarthritis is expected to dominate the market with a value of 1.5 billion USD by 2035.

    What is the market size for Spinal Osteoarthritis in 2024?

    In 2024, the market size for Spinal Osteoarthritis is expected to be 0.5 billion USD.

    Which companies are considered key players in the US Osteoarthritis Market?

    Key players include Teva Pharmaceutical Industries, Merck and Co., Takeda Pharmaceutical Company, and Bristol-Myers Squibb.

    What is the projected market growth rate for Hip Osteoarthritis from 2024 to 2035?

    The market for Hip Osteoarthritis is projected to grow from 0.6 billion USD in 2024 to 1.5 billion USD by 2035.

    What challenges could impact the growth of the US Osteoarthritis Market?

    Challenges include stringent regulatory requirements and high treatment costs affecting accessibility.

    What opportunities exist for growth in the US Osteoarthritis Market?

    Opportunities include advancements in treatment methodologies and increasing awareness about osteoarthritis management.

    How does regional demand impact the US Osteoarthritis Market?

    Regional demand is influenced by factors like population aging and prevalence rates, particularly in urban areas.

    Download Free Sample

    Kindly complete the form below to receive a free sample of this Report

    Case Study
    Chemicals and Materials